Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-08-000839
Filing Date
2008-08-18
Accepted
2008-08-18 17:27:04
Documents
2
Group Members
ANDREEFF EQUITY ADVISORS, L.L.C.MAPLE LEAF CAPITAL I, L.L.C.

Document Format Files

Seq Description Document Type Size
1 sc13g-a_ardeabios.txt SC 13G/A 12380
2 exh99.txt EX-99 1473
  Complete submission text file 0000898432-08-000839.txt   15928
Mailing Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121 760-602-8422
Ardea Biosciences, Inc./DE (Subject) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59411 | Film No.: 081025813
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL ST STE 2105 BATON ROUGE LA 70801
Business Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL STREET STE 2105 BATON ROUGE LA 70801 2253447780
ANDREEFF DANE (Filed by) CIK: 0001201810 (see all company filings)

Type: SC 13G/A